These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27241015)

  • 61. The cocaine and heroin markets in the era of globalisation and drug reduction policies.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Nov; 20(6):488-96. PubMed ID: 19447024
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Global patterns of domestic cannabis cultivation: sample characteristics and patterns of growing across eleven countries.
    Potter GR; Barratt MJ; Malm A; Bouchard M; Blok T; Christensen AS; Decorte T; Frank VA; Hakkarainen P; Klein A; Lenton S; Perälä J; Werse B; Wouters M
    Int J Drug Policy; 2015 Mar; 26(3):226-37. PubMed ID: 25582281
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Calibrating law enforcement and its purpose.
    Felbab-Brown V
    Addiction; 2014 Dec; 109(12):1969-70. PubMed ID: 25384931
    [No Abstract]   [Full Text] [Related]  

  • 64. Effect of restricting the legal supply of prescription opioids on buying through online illicit marketplaces: interrupted time series analysis.
    Martin J; Cunliffe J; Décary-Hétu D; Aldridge J
    BMJ; 2018 Jun; 361():k2270. PubMed ID: 29899119
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trafficking in meth: an analysis of the differences between male and female dealers.
    Senjo SR
    J Drug Educ; 2005; 35(1):59-77. PubMed ID: 16270698
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adapting the Illicit Drug Reporting System (IDRS) to examine the feasibility of monitoring trends in the markets for 'party drugs'.
    Topp L; Breen C; Kaye S; Darke S
    Drug Alcohol Depend; 2004 Feb; 73(2):189-97. PubMed ID: 14725959
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterising the online weapons trafficking on cryptomarkets.
    Rhumorbarbe D; Werner D; Gilliéron Q; Staehli L; Broséus J; Rossy Q
    Forensic Sci Int; 2018 Feb; 283():16-20. PubMed ID: 29245040
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Yet another dimension of the ineffectiveness of supply-side interventions in illegal drug markets.
    Mejia D
    Addiction; 2014 Dec; 109(12):1968-9. PubMed ID: 25384930
    [No Abstract]   [Full Text] [Related]  

  • 69. Preliminary findings of the impact of COVID-19 on drugs crypto markets.
    Bergeron A; Décary-Hétu D; Giommoni L
    Int J Drug Policy; 2020 Sep; 83():102870. PubMed ID: 32741719
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Monitoring the size and protagonists of the drug market: combining supply and demand data sources and estimates.
    Rossi C
    Curr Drug Abuse Rev; 2013 Jun; 6(2):122-9. PubMed ID: 24308521
    [TBL] [Abstract][Full Text] [Related]  

  • 71. "Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web.
    Corazza O; Valeriani G; Bersani FS; Corkery J; Martinotti G; Bersani G; Schifano F
    J Psychoactive Drugs; 2014; 46(4):287-94. PubMed ID: 25188698
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cannabis policies and user practices: market separation, price, potency, and accessibility in Amsterdam and San Francisco.
    Reinarman C
    Int J Drug Policy; 2009 Jan; 20(1):28-37. PubMed ID: 18367390
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A replication and methodological critique of the study "Evaluating drug trafficking on the Tor Network".
    Munksgaard R; Demant J; Branwen G
    Int J Drug Policy; 2016 Sep; 35():92-6. PubMed ID: 27079624
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A geographical analysis of trafficking on a popular darknet market.
    Broséus J; Rhumorbarbe D; Morelato M; Staehli L; Rossy Q
    Forensic Sci Int; 2017 Aug; 277():88-102. PubMed ID: 28624673
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sellers' risk perceptions in public and private social media drug markets.
    Bakken SA; Demant JJ
    Int J Drug Policy; 2019 Nov; 73():255-262. PubMed ID: 31053409
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cannabis 'tinny' houses in New Zealand: implications for the use and sale of cannabis and other illicit drugs in New Zealand.
    Wilkins C; Reilly JL; Casswell S
    Addiction; 2005 Jul; 100(7):971-80. PubMed ID: 15955013
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Two ways of estimating the euro value of the illicit market for cannabis in France.
    Legleye S; Ben Lakhdar C; Spilka S
    Drug Alcohol Rev; 2008 Sep; 27(5):466-72. PubMed ID: 18696293
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Retail price as an outcome measure for the effectiveness of drug law enforcement.
    Bright DA; Ritter A
    Int J Drug Policy; 2010 Sep; 21(5):359-63. PubMed ID: 20083399
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Research as due diligence: What can supply-side interventions accomplish and at what cost?
    Greenfield VA; Paoli L
    Int J Drug Policy; 2017 Mar; 41():162-163. PubMed ID: 28257908
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Drug use data, drug use theories and drug use policies in the United States: a combinatorial lack of connections.
    Des Jarlais D
    Addiction; 2015 May; 110(5):739-40. PubMed ID: 25868539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.